Privateer Holdings

Investment firm (auto-created from funding round data)

Active

Updated: Dec 10, 2025 ·

Recent News & Mentions

Jan 1, 2018FundingPrivateer Holdings - Series C Apr 1, 2015FundingPrivateer Holdings - Series B Jan 1, 2013FundingPrivateer Holdings - Series A

Financial History

Privateer Holdings has raised $182.0M across 3 funding rounds. Most recently, it raised $100.0M Series C in January 2018.

Total Raised

$182.0M

Valuation

N/A

Funding Rounds Raised

Date	Round	Other Investors
Jan 1, 2018	$100.0M Series C	Endeavor Health Ventures
Apr 1, 2015	$75.0M Series B	AME Cloud Ventures, B Capital Group, Bedrock Capital, David Namdar, Greylock, Hardware Club, Khosla Ventures, Morado Venture Partners, NEO, OS Fund, Bart Swanson, Hadi Partovi, Kevin Colas, Marc Benioff, Scott Banister
Jan 1, 2013	$7.0M Series A	Endeavor Health Ventures

Financial History

Privateer Holdings has raised $182.0M across 3 funding rounds.

Total Raised

$182.0M

Valuation

N/A

Deep Dive

High-Level Overview

Privateer Holdings is a Seattle-based private equity firm founded to shape the future of the legal cannabis industry through investments in mainstream brands and companies.[1][2][3][4] Its mission centers on three core beliefs: cannabis as a mainstream product for everyday consumers, the inevitability of ending cannabis prohibition, and the pivotal role of brands in defining the industry's future.[2] The firm's investment philosophy emphasizes professionalizing cannabis businesses via strategic acquisitions, incubations, and 100% ownership of portfolio companies, targeting the global legal cannabis market.[1][2][4] Key sectors include cannabis production, distribution, retail platforms, and consumer brands, with notable investments like Leafly (a cannabis information platform), Tilray (medical cannabis producer), and Marley Natural (lifestyle brand).[1]

Privateer has significantly impacted the startup ecosystem by securing the first institutional investor in cannabis—Founders Fund—and pioneering milestones such as Leafly's 2014 New York Times ad and Tilray's exports to Australia, Brazil, and Europe, legitimizing the sector amid regulatory evolution.[1][2]

Origin Story

Privateer Holdings was founded on October 20, 2011, by Brendan Kennedy, Michael Blue, and Chris Groh—three entrepreneurs with prior experience in financial services and strategic consulting.[1][2][3] The trio launched the firm in Seattle amid early U.S. state-level cannabis legalization, aiming to build a portfolio of global brands in a nascent, prohibition-constrained market.[1][4] Key early moves included acquiring Leafly in 2011, investing in Tilray (a federally licensed Canadian medical cannabis producer), and partnering with the Bob Marley estate in 2014 for Marley Natural, which debuted products in 2016.[1]

The firm's evolution accelerated with regulatory shifts: by 2017-2018, it closed a $100+ million Series C round and expanded internationally, employing over 350 people across seven countries; in 2019, it merged with portfolio company Tilray, marking a pivotal consolidation amid booming market opportunities.[1][2]

Core Differentiators

Unique Investment Model: Focuses on full ownership of incubated, acquired, or invested companies to build "world-leading brands" that legitimize cannabis as mainstream, rather than fragmented stakes.[1][2][4]
Network Strength: Secured pioneering institutional backing from Founders Fund and leveraged global partnerships, like the Marley family collaboration, to access new markets and cultural credibility.[1][2]
Track Record: Built high-profile exits and milestones, including Tilray's $122 million raise by 2016, Leafly's media breakthroughs, and Marley Natural's multi-state rollout; merged with Tilray in 2019 for scaled operations.[1]
Operating Support: Provides decades of financial, investment, and strategic expertise to professionalize cannabis businesses, navigating regulatory complexities in production, export, and branding.[1][2][4][5]

Role in the Broader Tech Landscape

Privateer rode the wave of cannabis legalization trends, starting with U.S. state reforms in 2011 and expanding to Canada's federal framework, positioning itself as a first-mover in a "rocketing" market projected for explosive growth.[1][2] Timing was critical: early entry amid prohibition's end allowed it to capitalize on regulatory openings, like Tilray's pioneering North American exports, while market forces—shifting public attitudes, medical demand, and global decriminalization—fueled portfolio expansion.[1]

The firm influenced the ecosystem by mainstreaming cannabis through branded, professional operations, attracting institutional capital, and demonstrating scalability in a controversial sector, paving the way for broader VC interest despite persistent federal risks in the U.S.[2][5]

Quick Take & Future Outlook

Post-2019 Tilray merger, Privateer operates within a larger public entity, likely amplifying its global reach in medical and recreational cannabis amid ongoing legalization (e.g., U.S. federal reforms, EU expansions).[1] Trends like pharmaceutical-grade products, international exports, and branded consumer goods will shape its path, with potential for further M&A or IPO leverage in maturing markets.[1][2] Its influence may evolve from pioneer investor to integrated operator, defining cannabis as a legitimate trillion-dollar industry—echoing its founding thesis that brands will lead prohibition's end.[2][4]

Sources

Frequently Asked Questions

How much funding has Privateer Holdings raised?

Privateer Holdings has raised $182.0M in total across 3 funding rounds.

Who are Privateer Holdings's investors?

Privateer Holdings's investors include Endeavor Health Ventures, AME Cloud Ventures, B Capital Group, Bedrock Capital, David Namdar, Greylock, Hardware Club, Khosla Ventures, Morado Venture Partners, NEO, OS Fund, Bart Swanson.